Literature DB >> 11852415

The effect of active surveillance for vancomycin-resistant enterococci in high-risk units on vancomycin-resistant enterococci incidence hospital-wide.

Anwer H Siddiqui1, Anthony D Harris, Joan Hebden, P David Wilson, J Glenn Morris, Mary-Claire Roghmann.   

Abstract

BACKGROUND: Vancomycin-resistant enterococci (VRE) have become a major cause of nosocomial infections and are now endemic in many geographic areas. The aim of this study was to describe the effect of active surveillance for patients with VRE in high-risk units on the VRE incidence rate hospital-wide.
METHODS: We determined 4 time periods based on the intervention of active surveillance: preactive surveillance (period 1), active surveillance (period 2), no active surveillance (period 3), and reinstutition of active surveillance (period 4). VRE incidence rates based on first clinical culture for VRE per 10,000 patient days for each of these periods and incidence rate ratios were then calculated.
RESULTS: Active surveillance in high-risk units was associated with a significant reduction in VRE incidence hospital-wide in 2 of the 3 comparisons made. The incidence rate ratio when comparing the first period of active surveillance (period 2) to the preactive surveillance period (period 1) was 0.63 (95% CI, 0.38-1.1); it was 0.36 (95% CI, 0.23-0.55) when comparing the first period of active surveillance (period 2) to the subsequent period (period 3) and 0.68 (95% CI, 0.54-0.85) when comparing the second period of active surveillance (period 4) to the prior period without active surveillance periods.
CONCLUSIONS: Active surveillance culturing for VRE in the high risk-units prevented further VRE transmission, as evidenced by a significant increase in hospital-wide incidence rates when active surveillance was discontinued and a significant decrease in incidence rates when it was restarted.

Entities:  

Mesh:

Year:  2002        PMID: 11852415     DOI: 10.1067/mic.2002.118616

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  6 in total

1.  Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission.

Authors:  Scott R Curry; Carlene A Muto; Jessica L Schlackman; A William Pasculle; Kathleen A Shutt; Jane W Marsh; Lee H Harrison
Journal:  Clin Infect Dis       Date:  2013-07-23       Impact factor: 9.079

Review 2.  Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis.

Authors:  C E Dandoy; M I Ardura; G A Papanicolaou; J J Auletta
Journal:  Bone Marrow Transplant       Date:  2017-03-27       Impact factor: 5.174

3.  Characterizing vancomycin-resistant enterococci in neonatal intensive care.

Authors:  C Rebecca Sherer; Bruce M Sprague; Joseph M Campos; Sumathi Nambiar; Rachel Temple; Billie Short; Nalini Singh
Journal:  Emerg Infect Dis       Date:  2005-09       Impact factor: 6.883

4.  Clinical practice guidelines for the provision of renal service in Hong Kong: Infection Control in Renal Service.

Authors:  Sing Leung Lui; Desmond Yap; Vincent Cheng; Tak Mao Chan; Kwok Yung Yuen
Journal:  Nephrology (Carlton)       Date:  2019-03       Impact factor: 2.506

5.  Epidemiology and control of an outbreak of vancomycin-resistant enterococci in the intensive care units.

Authors:  Young Kyung Yoon; Hee Sun Sim; Jeong Yeon Kim; Dae Won Park; Jang Wook Sohn; Kyung Ho Roh; Seung Eun Lee; Min Ja Kim
Journal:  Yonsei Med J       Date:  2009-10-21       Impact factor: 2.759

Review 6.  The state of the science.

Authors:  Barry M Farr
Journal:  Am J Infect Control       Date:  2004-04       Impact factor: 2.918

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.